Literature DB >> 28881417

Central and non-central networks, cognition, clinical symptoms, and polygenic risk scores in schizophrenia.

Clara Alloza1, Mark E Bastin2,3,4, Simon R Cox2,5,4, Jude Gibson1, Barbara Duff1, Scott I Semple6, Heather C Whalley1, Stephen M Lawrie1.   

Abstract

Schizophrenia is a complex disorder that may be the result of aberrant connections between specific brain regions rather than focal brain abnormalities. Here, we investigate the relationships between brain structural connectivity as described by network analysis, intelligence, symptoms, and polygenic risk scores (PGRS) for schizophrenia in a group of patients with schizophrenia and a group of healthy controls. Recently, researchers have shown an interest in the role of high centrality networks in the disorder. However, the importance of non-central networks still remains unclear. Thus, we specifically examined network-averaged fractional anisotropy (mean edge weight) in central and non-central subnetworks. Connections with the highest betweenness centrality within the average network (>75% of centrality values) were selected to represent the central subnetwork. The remaining connections were assigned to the non-central subnetwork. Additionally, we calculated graph theory measures from the average network (connections that occur in at least 2/3 of participants). Density, strength, global efficiency, and clustering coefficient were significantly lower in patients compared with healthy controls for the average network (pFDR  < 0.05). All metrics across networks were significantly associated with intelligence (pFDR  < 0.05). There was a tendency towards significance for a correlation between intelligence and PGRS for schizophrenia (r = -0.508, p = 0.052) that was significantly mediated by central and non-central mean edge weight and every graph metric from the average network. These results are consistent with the hypothesis that intelligence deficits are associated with a genetic risk for schizophrenia, which is mediated via the disruption of distributed brain networks. Hum Brain Mapp 38:5919-5930, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  connectivity; diffusion tensor MRI; genetics; intelligence; schizophrenia; symptoms

Mesh:

Substances:

Year:  2017        PMID: 28881417      PMCID: PMC6866958          DOI: 10.1002/hbm.23798

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  71 in total

1.  Disrupted axonal fiber connectivity in schizophrenia.

Authors:  Andrew Zalesky; Alex Fornito; Marc L Seal; Luca Cocchi; Carl-Fredrik Westin; Edward T Bullmore; Gary F Egan; Christos Pantelis
Journal:  Biol Psychiatry       Date:  2010-10-29       Impact factor: 13.382

2.  Correlations of diffusion tensor imaging values and symptom scores in patients with schizophrenia.

Authors:  Andrew M Michael; Vince D Calhoun; Godfrey D Pearlson; Stefi A Baum; Arvind Caprihan
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2008

3.  Disruptions in small-world cortical functional connectivity network during an auditory oddball paradigm task in patients with schizophrenia.

Authors:  Miseon Shim; Do-Won Kim; Seung-Hwan Lee; Chang-Hwan Im
Journal:  Schizophr Res       Date:  2014-05-10       Impact factor: 4.939

4.  The disconnection hypothesis.

Authors:  K J Friston
Journal:  Schizophr Res       Date:  1998-03-10       Impact factor: 4.939

5.  A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia.

Authors:  V Cheung; C Cheung; G M McAlonan; Y Deng; J G Wong; L Yip; K S Tai; P L Khong; P Sham; S E Chua
Journal:  Psychol Med       Date:  2007-10-22       Impact factor: 7.723

6.  Abnormal rich club organization and functional brain dynamics in schizophrenia.

Authors:  Martijn P van den Heuvel; Olaf Sporns; Guusje Collin; Thomas Scheewe; René C W Mandl; Wiepke Cahn; Joaquín Goñi; Hilleke E Hulshoff Pol; René S Kahn
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

Review 7.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

Review 8.  Human intelligence and brain networks.

Authors:  Roberto Colom; Sherif Karama; Rex E Jung; Richard J Haier
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Impact of cross-disorder polygenic risk on frontal brain activation with specific effect of schizophrenia risk.

Authors:  Heather C Whalley; Lynsey Hall; Liana Romaniuk; Alix Macdonald; Stephen M Lawrie; Jessika E Sussmann; Andrew M McIntosh
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

10.  PRSice: Polygenic Risk Score software.

Authors:  Jack Euesden; Cathryn M Lewis; Paul F O'Reilly
Journal:  Bioinformatics       Date:  2014-12-29       Impact factor: 6.937

View more
  10 in total

1.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 2.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

3.  Negative symptoms are associated with modularity and thalamic connectivity in schizophrenia.

Authors:  Adem Bayrakçı; Nabi Zorlu; Merve Karakılıç; Funda Gülyüksel; Berna Yalınçetin; Elif Oral; Fazıl Gelal; Emre Bora
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-03       Impact factor: 5.270

Review 4.  On the nature and use of models in network neuroscience.

Authors:  Danielle S Bassett; Perry Zurn; Joshua I Gold
Journal:  Nat Rev Neurosci       Date:  2018-09       Impact factor: 34.870

5.  Polygenic risk score for schizophrenia and structural brain connectivity in older age: A longitudinal connectome and tractography study.

Authors:  C Alloza; S R Cox; M Blesa Cábez; P Redmond; H C Whalley; S J Ritchie; S Muñoz Maniega; M Del C Valdés Hernández; E M Tucker-Drob; S M Lawrie; J M Wardlaw; I J Deary; M E Bastin
Journal:  Neuroimage       Date:  2018-09-01       Impact factor: 6.556

6.  The interactive effects of stress and coping style on cognitive function in patients with schizophrenia.

Authors:  Xiaodan Zhu; Xuebing Xu; Chao Xu; Jingyi Zhang; Xiaofeng Zhang; Li Ma; Juan Liu; Kefang Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-21       Impact factor: 2.570

7.  Familial t(1;11) translocation is associated with disruption of white matter structural integrity and oligodendrocyte-myelin dysfunction.

Authors:  Navneet A Vasistha; Mandy Johnstone; Samantha K Barton; Steffen E Mayerl; Bhuvaneish Thangaraj Selvaraj; Pippa A Thomson; Owen Dando; Ellen Grünewald; Clara Alloza; Mark E Bastin; Matthew R Livesey; Kyriakos Economides; Dario Magnani; Paraskevi Makedonopolou; Karen Burr; David J Story; Douglas H R Blackwood; David J A Wyllie; Andrew M McIntosh; J Kirsty Millar; Charles Ffrench-Constant; Giles E Hardingham; Stephen M Lawrie; Siddharthan Chandran
Journal:  Mol Psychiatry       Date:  2019-09-03       Impact factor: 15.992

8.  Polygenic Risk Scores Shed Light on the Relationship between Schizophrenia and Cognitive Functioning: Review and Meta-Analysis.

Authors:  Jasmina Mallet; Yann Le Strat; Caroline Dubertret; Philip Gorwood
Journal:  J Clin Med       Date:  2020-01-25       Impact factor: 4.241

9.  Development of Structural Covariance From Childhood to Adolescence: A Longitudinal Study in 22q11.2DS.

Authors:  Corrado Sandini; Daniela Zöller; Elisa Scariati; Maria C Padula; Maude Schneider; Marie Schaer; Dimitri Van De Ville; Stephan Eliez
Journal:  Front Neurosci       Date:  2018-05-18       Impact factor: 4.677

10.  Genetic Risk for Psychiatric Disorders and Telomere Length.

Authors:  Alish B Palmos; Gerome Breen; Laura Goodwin; Souci Frissa; Stephani L Hatch; Matthew Hotopf; Sandrine Thuret; Cathryn M Lewis; Timothy R Powell
Journal:  Front Genet       Date:  2018-10-16       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.